Observational study / 2007
Higher pre-diagnosis intakes of flavones, isoflavones, and anthocyanidins were linked to lower all-cause mortality in women with breast cancer.
Researchers followed 1,210 women newly diagnosed with first primary invasive breast cancer between 1996 and 1997 through 2002 to examine whether pre-diagnostic dietary flavonoid intake was associated with survival. Comparing the highest quintile of intake to the lowest, reduced age- and energy-adjusted hazard ratios for all-cause mortality were observed for flavones [0.63 (95% CI: 0.41-0.96)], isoflavones [0.52 (95% CI: 0.33-0.82)], and anthocyanidins [0.64 (95% CI: 0.42-0.98)], with similar results for breast cancer-specific mortality. However, no significant trends in risk across intake levels were observed.
Shows an association, not proof of cause and effect.
- Study type
- Population-based prospective cohort study
- Who was studied
- 1,210 women (ages 25-98) newly diagnosed with a first primary invasive breast cancer
- What was measured
- All-cause mortality and breast cancer-specific mortality
THE PAPER
Dietary flavonoid intake and breast cancer survival among women on Long Island.
Fink BN, Steck SE, Wolff MS, Britton JA, Kabat GC, Gaudet MM, Abrahamson PE, Bell P, Schroeder JC, Teitelbaum SL, Neugut AI, Gammon MD. Cancer Epidemiol Biomarkers Prev, 2007.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.